REQUEST A DEMO
Total
USD $0.00
Search more companies

Biropharma Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: BIROPHARMA Elso Magyar Biotechnologiai Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

BIROPHARMA Elso Magyar Biotechnologiai Kft is a Hungarian company that focuses on researching and developing special medical foods, plant medicines, and dietary supplements. Its main products include special preparations containing fermented beans extract. The company operates in the biotechnology and genetic industry, using DNA cloning technology. It claims to have a global target market.

Headquarters
IV. korzet 6.
Kunfeherto; Bacs-Kiskun; Postal Code: 6413

Contact Details: Purchase the Biropharma Kft. report to view the information.

Website: http://www.biropharma.hu

Basic Information
Total Employees:
Purchase the Biropharma Kft. report to view the information.
Outstanding Shares:
Purchase the Biropharma Kft. report to view the information.
Registered Capital:
Purchase the Biropharma Kft. report to view the information.
Financial Auditors:
Purchase the Biropharma Kft. report to view the information.
Incorporation Date:
June 12, 1998
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
BIZALOM EXPRESSZ Kft.
TAPSZER Elelmiszeripari Gyarto es Kereskedelmi Kft.
VNEW Ingatlanforgalmazo Korlatolt Feleloessegu Tarsasag
Company Performance
Financial values in the chart are available after Biropharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-8.03%
Total operating revenue
37.09%
Operating profit (EBIT)
N/A
EBITDA
294.83%
Net Profit (Loss) for the Period
71.97%
Total assets
-16.09%
Total equity
-7.26%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
20.93%
Return on Equity (ROE)
18.09%
Debt to Equity Ratio
-12.92%
Quick Ratio
-0.03%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?